Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Gastric prokinetic agents under development at Janssen

Nov. 7, 1997

New proton pump inhibitors from Apotex

Nov. 6, 1997

Lexipafant as adjunct for severe acute pancreatitis

Oct. 31, 1997

Roussel Morishita reports antiulcer agents with a novel mechanism of action

Oct. 31, 1997

AD-8717: a novel proton pump inhibitor in the pipeline at Dainippon

Oct. 30, 1997

Muscarinic receptor antagonists claimed by Pfizer for IBS, Alzheimer's disease

Oct. 30, 1997

Genome Therapeutics reaches milestone in H. pylori collaboration

Oct. 30, 1997

FDA clears generic cimetidine

Oct. 29, 1997

Hepatitis C-related technology available for licensing from NIH

Oct. 29, 1997

Shionogi presents potent and selective CCKB/gastrin receptor antagonist

Oct. 29, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...